Charles Hicks

Charles Hicks

UNVERIFIED PROFILE

Are you Charles Hicks?   Register this Author

Register author
Charles Hicks

Charles Hicks

Publications by authors named "Charles Hicks"

Are you Charles Hicks?   Register this Author

100Publications

1062Reads

28Profile Views

Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation.

J Acquir Immune Defic Syndr 2018 12;79(4):510-518

Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203616PMC
December 2018

A Wake-up Call for Human Immunodeficiency Virus (HIV) Providers: Obstructive Sleep Apnea in People Living With HIV.

Clin Infect Dis 2018 07;67(3):472-476

Division of Infectious Disease, University of California, San Diego, La Jolla.

View Article

Download full-text PDF

Source
https://academic.oup.com/cid/article/67/3/472/4994301
Publisher Site
http://dx.doi.org/10.1093/cid/ciy217DOI Listing
July 2018

Diminished physical function in older HIV-infected adults in the Southeastern U.S. despite successful antiretroviral therapy.

PLoS One 2017 29;12(6):e0179874. Epub 2017 Jun 29.

Claude D Pepper Older Americans Independence Center, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179874PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491055PMC
September 2017

Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment.

AIDS Res Ther 2017 Sep 20;14(1):56. Epub 2017 Sep 20.

Department of Medicine-Owen Clinic, University of California at San Diego, 200 W. Arbor Drive, San Diego, CA, 92103-8681, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12981-017-0182-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607579PMC
September 2017

Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.

AIDS 2016 11;30(18):2815-2822

aDepartment of Medicine, UNC Institute for Global Health & Infectious Diseases bDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill cDepartment of Medicine, Division of Infectious Diseases dDepartment of Surgery eDuke Human Vaccine Institute, Duke University, Durham fLaboratory Corporation of America, Burlington, North Carolina gDepartment of Clinical Medicine, University of San Diego, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101138PMC
November 2016

Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis.

AIDS Care 2016 19;28(4):475-82. Epub 2015 Oct 19.

d Division of Infectious Diseases, Department of Medicine , University of California , San Diego , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09540121.2015.1099602DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784685PMC
September 2016

Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease.

Open Forum Infect Dis 2016 Sep 29;3(3):ofw173. Epub 2016 Aug 29.

Duke University Medical Center, Durham; Durham Veterans Affairs Medical Center; Duke Clinical Research Institute, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047416PMC
http://dx.doi.org/10.1093/ofid/ofw173DOI Listing
September 2016

History of AIDS in HIV-Infected Patients Is Associated With Higher In-Hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke.

J Infect Dis 2016 06 3;213(12):1955-61. Epub 2016 Mar 3.

Duke Clinical Research Institute, Duke University Medical Center, Durham Department of Health Policy and Management, Gillings School of Global Public Health School of Medicine, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878727PMC
June 2016

Syphilis on the Rise: What Went Wrong?

JAMA 2016 Jun;315(21):2281-3

Department of Medicine, University of California, San Diego.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.7073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613539PMC
June 2016

Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks.

AIDS 2015 Nov;29(18):2459-64

aUniversity of Pennsylvania, Philadelphia, Pennsylvania bGeorgetown University School of Medicine, Washington, District of Columbia cUniversity of California San Diego Owen Clinic, San Diego, California, USA dGlaxoSmithKline, London, UK eGlaxoSmithKline, Philadelphia, Pennsylvania fGlaxoSmithKline, Research Triangle Park, North Carolina gViiV Healthcare, Research Triangle Park, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000863DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645955PMC
November 2015

Fever and Rash in a Patient With Hepatitis.

JAMA 2015 Jul;314(4):400-1

Divisions of General Internal Medicine/Infectious Diseases, University of California, San Diego.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2015.3401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612369PMC
July 2015

Treatment of late-stage syphilis--reply.

JAMA 2015 Mar;313(9):969-70

Division of Infectious Diseases, University of California, San Diego.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2015.0675DOI Listing
March 2015

The ongoing need for good physiological investigation: obstructive sleep apnea in HIV patients as a paradigm.

J Appl Physiol (1985) 2015 Jan 21;118(2):244-6. Epub 2014 Aug 21.

Division of Pulmonary, Critical Care and Sleep Medicine, University of California, San Diego, California.

View Article

Download full-text PDF

Source
http://www.physiology.org/doi/10.1152/japplphysiol.00656.201
Publisher Site
http://dx.doi.org/10.1152/japplphysiol.00656.2014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315452PMC
January 2015

Last Word on Viewpoint: The ongoing need for good physiological investigation: Obstructive sleep apnea in HIV patients as a paradigm.

J Appl Physiol (1985) 2015 Jan;118(2):251

Division of Pulmonary, Critical Care and Sleep Medicine, University of California, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/japplphysiol.00984.2014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839487PMC
January 2015

Treatment of syphilis: a systematic review.

JAMA 2014 Nov;312(18):1905-17

Divisions of General Internal Medicine and Infectious Diseases, University of California, San Diego.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.13259DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690208PMC
November 2014

RPR and the serologic diagnosis of syphilis.

JAMA 2014 Nov;312(18):1922-3

Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina2Dr Hicks is now with the Divisions of Internal Medicine and Infectious Diseases, University of California, San Diego.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.2087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690203PMC
November 2014

HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research.

J Acquir Immune Defic Syndr 2014 Sep;67 Suppl 1:S40-53

*Division of Cardiology, Department of Medicine and Duke Clinical Research Institute, Duke University, Durham, NC; †Duke Global Health Institute, Duke University, Durham, NC; ‡Departments of Medicine and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA; §National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD; ‖Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom; ¶Malawi-Liverpool-Wellcome Major Overseas Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi; #Divisions of Pulmonary and Critical Care Medicine; and **Infectious Diseases, Department of Medicine, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133739PMC
September 2014

Incident sexually transmitted infection as a biomarker for high-risk sexual behavior after diagnosis of acute HIV.

Sex Transm Dis 2014 Jul;41(7):447-52

From the *Department of Epidemiology and †School of Medicine, University of North Carolina at Chapel Hill, NC; and ‡School of Medicine, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/OLQ.0000000000000147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191902PMC
July 2014

Resistance to HIV integrase strand transfer inhibitors among clinical specimens in the United States, 2009-2012.

Clin Infect Dis 2014 Feb 21;58(3):423-31. Epub 2013 Oct 21.

Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cit697DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890334PMC
February 2014

A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.

Trials 2014 Jan 22;15:31. Epub 2014 Jan 22.

Department of Epidemiology, Rollins School of Public Health, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1745-6215-15-31DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901894PMC
January 2014

Updated recommendations on INSTI-based regimens for ART-naive patients.

Authors:
Charles B Hicks

J Watch AIDS Clin Care 2013 Dec;25(12):89

View Article

Download full-text PDF

Source
December 2013

Diagnosing HIV infection in primary care settings: missed opportunities.

AIDS Patient Care STDS 2013 Jul 25;27(7):392-7. Epub 2013 Jun 25.

Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/apc.2013.0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704080PMC
July 2013

Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation.

J Acquir Immune Defic Syndr 2013 Apr;62(5):505-8

Department of Medicine, Center for Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e318285cd33DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683110PMC
April 2013

Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons.

AIDS Res Hum Retroviruses 2013 Mar 7;29(3):435-40. Epub 2012 Nov 7.

Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/aid.2012.0234
Publisher Site
http://dx.doi.org/10.1089/aid.2012.0234DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581041PMC
March 2013

Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentation.

AIDS Res Hum Retroviruses 2012 Aug;28(8):789-92

Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 28374, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/AID.2011.0145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399555PMC
August 2012

Pre-exposure prophylaxis--one more tool for HIV prevention.

Curr HIV Res 2012 Mar;10(2):117-22

Division of Infectious Diseases, Vanderbilt Comprehensive Care Clinic, One Hundred Oaks, 719 Thompson Lane, Suite 37189, Nashville, TN 37204, USA.

View Article

Download full-text PDF

Source
March 2012

HIV treatment as prevention--the time is now.

Authors:
Charles B Hicks

J Watch AIDS Clin Care 2012 Jan;24(1)

View Article

Download full-text PDF

Source
January 2012

Growing the intense inhibitor class--Elvitegravir and Dolutegravir.

Authors:
Charles B Hicks

J Watch AIDS Clin Care 2012 Jan;24(1):5-6

View Article

Download full-text PDF

Source
January 2012

Profile of darunavir in the management of treatment-experienced HIV patients.

HIV AIDS (Auckl) 2009 29;1:13-21. Epub 2009 Sep 29.

Duke University Medical Center, Division of Infectious Diseases, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218680PMC
November 2011

Role of raltegravir in the management of HIV-1 infection.

HIV AIDS (Auckl) 2011 15;3:81-92. Epub 2011 Jul 15.

Duke University Medical Center, Department of Hospital Medicine, Durham Regional Hospital, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/HIV.S13985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218709PMC
November 2011

Evolution of drug-resistant viral populations during interruption of antiretroviral therapy.

J Virol 2011 Jul 13;85(13):6403-15. Epub 2011 Apr 13.

Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.02389-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126484PMC
July 2011

Investigational antiretrovirals--the pipeline is not dry.

Authors:
Charles B Hicks

J Watch AIDS Clin Care 2011 May;23(5):39

View Article

Download full-text PDF

Source
May 2011

Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment.

Antimicrob Agents Chemother 2011 Mar 20;55(3):1114-9. Epub 2010 Dec 20.

Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01492-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067114PMC
March 2011

A screen for deficiencies in GPI-anchorage of wall glycoproteins in yeast.

Yeast 2010 Aug;27(8):583-96

Department of Biology, Brooklyn College of the City University of New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/yea.1797DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050522PMC
August 2010

Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.

J Antimicrob Chemother 2010 Jun 25;65(6):1100-7. Epub 2010 Mar 25.

Division of Infectious Diseases, Department of Medicine, Northwestern University Medical School, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkq096DOI Listing
June 2010

Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options.

J Antimicrob Chemother 2010 Jun 23;65(6):1094-9. Epub 2010 Apr 23.

Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkq130DOI Listing
June 2010

Cyclosporine in acute and early HIV infection.

Authors:
Charles B Hicks

J Watch AIDS Clin Care 2010 Jun;22(6):54-5

View Article

Download full-text PDF

Source
June 2010

Report from the 17th Conference on Retroviruses and Opportunistic Infections. Four antiretrovirals in one?

Authors:
Charles B Hicks

J Watch AIDS Clin Care 2010 Apr;22(4):30-1

View Article

Download full-text PDF

Source
April 2010

Lipid changes associated with antiretroviral therapy: results differ by reporting approach.

Curr HIV Res 2009 Sep;7(5):547-54

Division of Endocrinology, Department of Internal Medicine, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
September 2009

Raltegravir: the first HIV type 1 integrase inhibitor.

Clin Infect Dis 2009 Apr;48(7):931-9

Duke University Medical Center, Weill Medical College of Cornell University, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/597290DOI Listing
April 2009

Report from the 16th Conference on Retroviruses and Opportunistic Infections. Investigational pharmacologic boosters.

Authors:
Charles B Hicks

J Watch AIDS Clin Care 2009 Apr;21(4):33-4

View Article

Download full-text PDF

Source
April 2009

Top stories of 2008. Beyond abacavir/3TC: good news on first-line regimens.

Authors:
Charles B Hicks

AIDS Clin Care 2009 Jan;21(1)

View Article

Download full-text PDF

Source
January 2009

Cost-effectiveness of tipranavir in treatment-experienced HIV patients in the United States.

HIV Clin Trials 2008 Jul-Aug;9(4):225-37

Medical University of South Carolina, Charleston, South Carolina 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1310/hct0904-225DOI Listing
October 2008

Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.

Authors:
Charles B Hicks

AIDS Clin Care 2008 Aug;20(8):64

View Article

Download full-text PDF

Source
August 2008

Does antiretroviral therapy prevent HIV transmission to sexual partners?

Curr Infect Dis Rep 2008 May;10(2):140-5

Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, 34225 Hospital South, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
May 2008

Report from the 15th Retrovirus Conference. Is abacavir therapy associated with MI risk?

Authors:
Charles B Hicks

AIDS Clin Care 2008 Apr;20(4):29

View Article

Download full-text PDF

Source
April 2008

Does antiretroviral therapy prevent HIV transmission to sexual partners?

Curr HIV/AIDS Rep 2007 May;4(2):80-5

Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, 34225 Hospital South, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
May 2007

Late diagnosis of HIV infection: the role of age and sex.

Am J Med 2007 Apr;120(4):370-3

Division of Infectious Diseases and International Health, Department of Medicine, University of Alabama at Birmingham, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029343060067
Publisher Site
http://dx.doi.org/10.1016/j.amjmed.2006.05.050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184035PMC
April 2007

Darunavir: an overview of an HIV protease inhibitor developed to overcome drug resistance.

AIDS Read 2007 Mar;17(3):151-6, 159-61

Division of Infectious Diseases, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
March 2007

Detection of minor drug-resistant populations by parallel allele-specific sequencing.

Nat Methods 2007 Feb 7;4(2):123-5. Epub 2007 Jan 7.

Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nmeth995DOI Listing
February 2007

Report from the XVI International AIDS Conference. Integrase inhibitors.

Authors:
Charles B Hicks

AIDS Clin Care 2006 Nov;18(11):101

View Article

Download full-text PDF

Source
November 2006

Management of the highly experienced patient.

Authors:
Charles Hicks

Curr Opin HIV AIDS 2006 Sep;1(5):424-9

Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.COH.0000239855.07367.46DOI Listing
September 2006

New antiretroviral drugs.

Curr HIV/AIDS Rep 2006 Jul;3(2):93-101

Duke University Medical Center, Division of Infectious Diseases and International Health, Box 3879, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
July 2006

Report from the 13th retrovirus conference. Integrase inhibitors on the way.

Authors:
Charles B Hicks

AIDS Clin Care 2006 Apr;18(4):33-4

View Article

Download full-text PDF

Source
April 2006

Report from the 13th retrovirus conference. New data on TMC114 and TMC125.

Authors:
Charles B Hicks

AIDS Clin Care 2006 Apr;18(4):34

View Article

Download full-text PDF

Source
April 2006

Antiretroviral rounds. Entrance left: the endocrinologist.

AIDS Clin Care 2006 Feb;18(2):18-9

View Article

Download full-text PDF

Source
February 2006

Impact of HIV protease inhibitor resistance in treatment-naive populations in the united states.

Authors:
Charles Hicks

AIDS Read 2005 Dec;15(12):683-6, 689-90

Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
December 2005

Meeting notes from the 3rd IAS Conference. Old drugs, new data.

Authors:
Charles B Hicks

AIDS Clin Care 2005 Oct;17(10):94-5

View Article

Download full-text PDF

Source
October 2005

Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection.

J Antimicrob Chemother 2005 Aug 30;56(2):273-6. Epub 2005 Jun 30.

Department of Internal Medicine, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dki209DOI Listing
August 2005

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection.

Expert Opin Pharmacother 2005 Aug;6(9):1573-85

Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.6.9.1573DOI Listing
August 2005

Calcium ligation in photosystem II under inhibiting conditions.

Biophys J 2005 Jul;89(1):393-401

School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000634950572689
Publisher Site
http://dx.doi.org/10.1529/biophysj.105.059667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1366539PMC
July 2005

Report from the 12th Retrovirus Conference. Acute and recent HIV infection.

Authors:
Charles B Hicks

AIDS Clin Care 2005 Apr;17(4):33-4

View Article

Download full-text PDF

Source
April 2005